US equities
|
MU
$1,097.39
▲+0.00%
NVDA
$230.86
▲+0.00%
MSTR
$160.50
▲+0.00%
SNDK
$1,787.69
▲+0.00%
INTC
$120.00
▲+0.00%
NKE
$35.15
▲+0.00%
AMD
$615.73
▲+0.00%
AVGO
$343.64
▲+0.00%
MU
$1,097.39
▲+0.00%
NVDA
$230.86
▲+0.00%
MSTR
$160.50
▲+0.00%
SNDK
$1,787.69
▲+0.00%
INTC
$120.00
▲+0.00%
NKE
$35.15
▲+0.00%
AMD
$615.73
▲+0.00%
AVGO
$343.64
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Leap Therapeutics, Inc. - Common Stock
(NQ:
LPTX
)
2.060
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 12, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Leap Therapeutics, Inc. - Common Stock
TOMI Environmental (NASDAQ: TOMZ) | Norovirus Strain Shift Exposes Urgent Need for Next-Generation Disinfection
November 12, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Nika Pharmaceuticals (OTCQB: NIKA) Advances Immune-Based Drug Portfolio Targeting HIV, Cancer, and Chronic Diseases
November 12, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Roadzen Inc. (NASDAQ: RDZN) Completes $7M India Financing at 100% Premium – Paves Path to Higher Valuation | More Stocks Inside
October 06, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
October 06, 2025
EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:LPTX),(NASDAQ:IOBT),(NASDAQ:CELC),(NYSE:MAIA) EQNX::TICKER_END
Via
FinancialNewsMedia
Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment
March 26, 2025
Via
AB Newswire
Topics
Artificial Intelligence
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
October 23, 2023
Via
ACCESSWIRE
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
Via
MarketBeat
LPTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Leap Therapeutics, Inc. Is Fair to Shareholders
January 24, 2023
From
Halper Sadeh LLC
Via
Business Wire
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
January 20, 2022
Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to...
Via
FinancialNewsMedia
Topics
Death
Why Pharmaceutical Companies in Ovarian Cancer Drugs Market are Betting Big on R&D
September 17, 2021
Via
FinancialNewsMedia
Topics
Death
